Curio Bioscience
Curio Bioscience is a Palo Alto-based spatial genomics company that developed the Trekker Single-Cell Spatial Mapping Kit and Seeker Spatial Transcriptomics Kit for life science researchers, serving cancer, developmental, immunology, and neuroscience applications before being acquired by Takara Bio in February 2026.
- Company typePrivate
- Founded-
- HeadquartersPalo Alto, United States
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Curio Bioscience does
Curio Bioscience is a Palo Alto-based, privately held life science tools company that developed spatial genomics and spatial transcriptomics kits for single-cell analysis. The company's core offerings consisted of two products: the Trekker Single-Cell Spatial Mapping Kit, a one-hour, instrument-free solution that enables researchers to pinpoint the exact locations of single cells upstream of single-nuclei NGS assays, and the Seeker Spatial Transcriptomics Kit, which captures whole transcriptomes of single cells with flexible array sizes and is designed to work across any species rather than being limited to human or mouse samples. Together, these products positioned Curio in the high-growth spatial omics segment of the next-generation sequencing market, targeting life science researchers and genomics laboratories working in cancer biology, developmental biology, immunology, and neuroscience.
The company's business model centered on selling consumable kits through parent company Takara Bio's global distribution network, which included direct sales representatives, an online storefront, and a certified service provider program. Marketing leveraged Takara Bio's content channels, including the BioView blog, technical webinars, and industry conferences. Pricing was not publicly disclosed. Curio was a small organization, with employee count reported in the 11-50 range, and was co-founded by Ari Chaney, who served as COO.
In February 2026, Curio Bioscience was acquired by Takara Bio, a strategic operating company in the biotechnology tools space. The acquisition was driven by Takara Bio's strategy to expand its spatial genomics capabilities and integrate Curio's Trekker and Seeker technologies into its broader NGS portfolio. Following the transaction, Curio ceased operating as an independent company and its products became part of Takara Bio's spatial omics product line.
Curio Bioscience firmographics
Firmographics- Name
- Curio Bioscience
- Website
- https://curiobioscience.com
- Company type
- Private
- Operating status
- Acquired
- Headcount range
- 11–50 employees
- Short description
- Curio Bioscience is a Palo Alto-based spatial genomics company that developed the Trekker Single-Cell Spatial Mapping Kit and Seeker Spatial Transcriptomics Kit for life science researchers, serving cancer, developmental, immunology, and neuroscience applications before being acquired by Takara Bio in February 2026.
- Ownership category
- akta.pro rank
Curio Bioscience industry classification
Industry- Product category
- Spatial Genomics Reagents
- NAICS
- Biological Product (except Diagnostic) Manufacturing (325414), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
- SIC
- Biological Products, (No Disgnostic Substances) (2836)
- akta.pro primary industry
- Single-Cell & Spatial Omics Services (HLAGANAC)
- akta.pro secondary industry
- Single-Cell & Spatial Omics Discovery Platforms (target ID/validation, functional profiling) (HLAAAIAF)
Keywords
Where Curio Bioscience is headquartered
LocationHeadquarters
- HQ city
- Palo Alto
- HQ country
- United States
- HQ region
- North America
Markets served
Curio Bioscience business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations
Distribution channels3 records
Marketing channels3 records
Curio Bioscience product offering
Product offeringCore offering
Curio Bioscience develops spatial omics kits that enable researchers to map the exact locations of single cells within tissue samples and capture whole-transcriptome gene expression with spatial context. Its two flagship products—the Trekker Single-Cell Spatial Mapping Kit and the Seeker Spatial Transcriptomics Kit—are wet-lab kits used upstream of single-nuclei NGS assays to provide single-cell spatial genomics without requiring expensive dedicated instrumentation.
Product overview
Curio Bioscience was a spatial genomics company acquired by Takara Bio to expand its spatial genomics capabilities. The company's core offerings consisted of two spatial omics technologies: the Trekker Single-Cell Spatial Mapping Kit and the Seeker Spatial Transcriptomics Kit. These technologies enabled researchers to examine single-cell location and behavior, providing spatial context to gene expression data. Following the acquisition by Takara Bio, these spatial omics products became part of Takara Bio's next-generation sequencing portfolio.
Differentiator
Problem solved
Functional benefit
Products and services
- Trekker Single-Cell Spatial Mapping Kit A one-kit spatial mapping solution that allows researchers to pinpoint the exact locations of single cells within tissue samples upstream of single-nuclei NGS assays, delivering a complete spatial picture of single cells without requiring expensive dedicated instrumentation.
- Seeker Spatial Transcriptomics Kit A flexible spatial transcriptomics kit offered in two array sizes that captures the whole transcriptome of single cells with spatial context, using a universal workflow applicable to any species rather than being limited to human and mouse.
Quantifiable outcome
- Next-generation sequencing technology segment growing at projected CAGR of 21.2%
Companies that use Curio Bioscience
Customer profileSegments1 record
Ideal customer profiles2 records
Curio Bioscience technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature2 records
Curio Bioscience partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Takara BiocoreTakara Bio acquired Curio Bioscience to expand its spatial genomics capabilities. This acquisition positions Curio Bioscience's spatial omics technologies, including the Trekker and Seeker spatial mapping kits, as part of Takara Bio's comprehensive portfolio. The acquisition enables Takara Bio to strengthen its presence in the growing spatial genomics market.
Scale indicators3 records
Recent moves5 records
Expansion highlights4 records
Curio Bioscience competitors and assessment
Company assessmentDirect peers
- NanoString Technologies (Bruker Spatial Biology): Direct peer offering spatial omics solutions (CosMx SMI, GeoMx DSP) that compete head-to-head with Curio's single-cell spatial mapping kits for the same translational and academic research customers.
- 10x Genomics: Direct competitor in single-cell and spatial transcriptomics, offering the Visium HD and Xenium platforms that overlap directly with Curio's Trekker and Seeker kits in target customers and applications.
- Standard BioTools: Formerly Fluidigm, offers single-cell genomics instrumentation and assays that compete with Curio's instrument-free, kit-based single-cell spatial workflow for similar core facility customers.
- Resolve Biosciences: Emerging spatial omics player offering single-cell, subcellular resolution transcriptomics that overlaps with Curio's high-resolution spatial mapping positioning.
- Akoya Biosciences: Direct peer in spatial biology with PhenoCycler and PhenoImager platforms; competes for the same immuno-oncology and tumor microenvironment research dollars as Curio's spatial kits.
- Vizgen: Direct competitor with the MERFISH-based spatial transcriptomics platform, serving the same single-cell spatial genomics use cases Curio addresses with Trekker and Seeker.
Broad incumbents
- Illumina: Broad incumbent in NGS whose sequencers underpin the downstream read-out for Curio's kits; competing also via partnerships with spatial omics players, making it a strategic ecosystem peer.
- Takara Bio: Parent company and broad incumbent in life science tools, offering the larger SMART-Seq NGS portfolio into which Curio's spatial omics kits have now been integrated post-acquisition.
- Bio-Techne: Broad life science tools incumbent with spatial biology (RNAscope) and proteomics reagents that compete broadly with Curio's spatial transcriptomics reagents for the same research end users.
Emerging players
- Parse Biosciences: Single-cell sequencing company whose Evercode technology complements Curio's single-cell upstream workflows; partial overlap on single-cell NGS but without spatial context.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat3 records
Key risks5 records
Key highlights6 records
Customer concentration
Curio Bioscience social profiles
Digital presenceCurio Bioscience financial estimates
Financial estimateRevenue estimate
Valuation estimate
Curio Bioscience leadership team
Management profileNumber of profiles
Profiles1 record
Curio Bioscience funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Curio Bioscience M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Curio Bioscience
What does Curio Bioscience do?
Curio Bioscience develops spatial omics kits that enable researchers to map the exact locations of single cells within tissue samples and capture whole-transcriptome gene expression with spatial context. Its two flagship products—the Trekker Single-Cell Spatial Mapping Kit and the Seeker Spatial Transcriptomics Kit—are wet-lab kits used upstream of single-nuclei NGS assays to provide single-cell spatial genomics without requiring expensive dedicated instrumentation.
Is Curio Bioscience a public or private company?
Curio Bioscience is a private company. It is classified as corporate owned and is currently acquired.
When was Curio Bioscience founded?
Curio Bioscience was founded in -1. It employs 11 to 50 people.
Where is Curio Bioscience based?
Curio Bioscience is headquartered in Palo Alto, United States, in the North America region.
Who are Curio Bioscience's main competitors?
Direct peers on record are NanoString Technologies (Bruker Spatial Biology), 10x Genomics, Standard BioTools, Resolve Biosciences, Akoya Biosciences and Vizgen. Broad incumbents are Illumina, Takara Bio and Bio-Techne. Parse Biosciences is listed as an emerging player.
Does Curio Bioscience have an API?
No public API is recorded for Curio Bioscience.
What industry is Curio Bioscience in?
Curio Bioscience's product category is Spatial Genomics Reagents. Its primary akta.pro industry code is HLAGANAC, Single-Cell & Spatial Omics Services, with a secondary code of HLAAAIAF, Single-Cell & Spatial Omics Discovery Platforms (target ID/validation, functional profiling). Its NAICS code is 325414 and its SIC code is 2836.